About: Antonio Anzueto

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antonio Anzueto Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) 研究者 (ja) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh)
rdfs:label	Antonio Anzueto (en) Antonio Anzueto (es) Antonio Anzueto (nl) Antonio Anzueto (ast)
skos:prefLabel	Antonio Anzueto (en) Antonio Anzueto (es) Antonio Anzueto (nl) Antonio Anzueto (ast)
name	Antonio Anzueto (en) Antonio Anzueto (es) Antonio Anzueto (nl) Antonio Anzueto (ast)
given name	wds:Q64039844-A3899BC0-A077-4A98-AF71-6DB3D2570892
given name	Antonio
instance of	wds:Q64039844-A96CADEA-FCCA-4D1E-BCC4-49AB69ED38FF
instance of	Homo sapiens
occupation	wds:Q64039844-B36F56C7-60EA-4787-94A6-638D605049AE
NUKAT ID	wds:Q64039844-C42922AF-3924-4B51-A163-9BF5A3F4E10C
sex or gender	wds:Q64039844-0500715e-4c92-ac0f-1c85-6f5c3d6fe9a1
ISNI	wds:Q64039844-E1F8658B-DB2A-4C96-97AF-D513E469A922
VIAF ID	wds:Q64039844-61326908-77C4-4AB7-9E4D-082EFF49EDE2
IdRef ID	wds:Q64039844-e12ef044-867a-48f3-a705-417df71d2e00
date of birth	wds:Q64039844-5ACCB4CA-B360-4953-A62B-5D48F0C65419
PLWABN ID	wds:Q64039844-42E89FF0-50B6-48E8-8F93-FC347D60F014
family name	wds:Q64039844-7301d424-4698-b6e8-26d7-494dc7ca918f
WorldCat Identities ID (superseded)	wds:Q64039844-BCE81950-304E-406C-853D-306DF8825C5C
National Library of Israel J9U ID	wds:Q64039844-5C33AB98-152C-4E0A-8799-40FDE96A9358
VIAF ID	http://viaf.org/viaf/232683021
IdRef ID	http://www.idref.fr/189057076/id
occupation	researcher
NUKAT ID	n2007006966
sex or gender	male
ISNI	0000000033396049
VIAF ID	232683021
IdRef ID	189057076
date of birth	1955-01-01 00:00:00Z (xsd:dateTime)
PLWABN ID	9810577178605606
family name	Anzueto
WorldCat Identities ID (superseded)	lccn-n99808068
National Library of Israel J9U ID	987007328279205171
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64039844
is author of	Long-term prognosis in community-acquired pneumonia Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study Characteristics and outcomes of ventilated patients according to time to liberation from mechanical ventilation. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material Management and outcome of mechanically ventilated neurologic patients. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia Impact of statins and ACE inhibitors on mortality after COPD exacerbations Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Prediction of death and prolonged mechanical ventilation in acute lung injury International study of the prevalence and outcomes of infection in intensive care units Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome Noninvasive positive-pressure ventilation for respiratory failure after extubation. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation Outcome of mechanically ventilated patients who require a tracheostomy. Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy Moxifloxacin: a respiratory fluoroquinolone Tiotropium Respimat inhaler and the risk of death in COPD. Airway pressures and early barotrauma in patients with acute lung injury and acute respiratory distress syndrome Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Patient's perception of exacerbations of COPD--the PERCEIVE study Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Pneumonia: an arrhythmogenic disease? The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trial Corticosteroids for Severe Community-Acquired Pneumonia: Time to Change Clinical Practice. Exacerbations of chronic obstructive pulmonary disease. Airway pressures, tidal volumes, and mortality in patients with acute respiratory distress syndrome. Ventilator-associated pneumonia in adults in developing countries: a systematic review Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet? Economic burden of ventilator-associated pneumonia based on total resource utilization Impact of body weight on critically ill patients: a heavy load!! Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia Novel targets in the management of pneumonia A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software